An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
Figure 1
Genomic profiles of responders and nonresponders. Genomic profiles of responders and nonresponders to the bevacizumab/irinotecan regimen. For each chromosome, the telomere of the short arm is on the left and the telomere of the long arm is on the right. The -axis corresponds to the frequency of gains and losses in each group of patients.
